Research Progress in Calcitonin Gene-Related Peptide and Bone Repair

Biomolecules. 2023 May 15;13(5):838. doi: 10.3390/biom13050838.

Abstract

Calcitonin gene-related peptide (CGRP) has 37 amino acids. Initially, CGRP had vasodilatory and nociceptive effects. As research progressed, evidence revealed that the peripheral nervous system is closely associated with bone metabolism, osteogenesis, and bone remodeling. Thus, CGRP is the bridge between the nervous system and the skeletal muscle system. CGRP can promote osteogenesis, inhibit bone resorption, promote vascular growth, and regulate the immune microenvironment. The G protein-coupled pathway is vital for its effects, while MAPK, Hippo, NF-κB, and other pathways have signal crosstalk, affecting cell proliferation and differentiation. The current review provides a detailed description of the bone repair effects of CGRP, subjected to several therapeutic studies, such as drug injection, gene editing, and novel bone repair materials.

Keywords: bone repair; calcitonin gene-related peptide; immunomodulation; osteogenic effect.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Remodeling
  • Bone Resorption*
  • Calcitonin Gene-Related Peptide* / genetics
  • Humans
  • NF-kappa B
  • Osteogenesis

Substances

  • Calcitonin Gene-Related Peptide
  • NF-kappa B

Grants and funding

This research was continuously funded by National Natural Science Foundation of China (No. 82172432; 82001319 and 82102568), National & Local Joint Engineering Research Center of Orthopaedic Biomaterials (XMHT20190204007), Shenzhen Key Laboratory of Orthopedic Diseases and Biomaterials Research (ZDSYS20220606100602005), Shenzhen Key Medical Discipline Construction Fund (No. SZXK023), Shenzhen “San-Ming” Project of Medicine (No. SZSM201612092), Research and Development Projects of Shenzhen (No. Z2021N054), and Shenzhen Science and Technology Program (No. JCYJ20210324110214040 and JCYJ20190809152409606).